why choose us

First received: August 20, 2024

Clinical Trial: A Study to Test Whether BI 456906 (Survodutide) Influences the Amount of Bupropion, Caffeine and Midazolam in the Blood in People With Overweight or Obesity

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Overweight

Study Type: INTERVENTIONAL


Official Title: An Open-label, Non-randomised, Fixed-sequence, Two Period, Phase I Trial to Evaluate the Effect of Different Doses of BI 456906 (Survodutide) on the Single Dose Pharmacokinetics of Bupropion, Caffeine

Brief Summary: This study is open to adults with overweight or obesity who are otherwise healthy.People can join the study if they have a body mass index of 27 to 39.9 kg/m2 and a body weight over 70 kg.The purpose of this study is to find out whether taking multiple doses of BI 456906 influences the amount of bupropion, caffeine, and midazolam in the blood.The study has 2 treatment periods.In Period 1, participants take 1 dose each of midazolam, caffeine, and bupropion as tablets or oral solution on separate days.In Period…

Read more